Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Urologic Oncology
|
May 18, 2023
Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population
Braden Millan, Rodney H Breau, Ranjeeta Mallick, et al.
Advances in Radiation Oncology
|
July 11, 2022
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System
Eric K Nguyen, Aly Khan A Lalani, Sunita Ghosh, et al.
JNCI Cancer Spectrum
|
December 20, 2021
Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate Cancer
Christopher J D Wallis, Shawn Malone, Ilias Cagiannos, et al.
Clinical Genitourinary Cancer
|
June 23, 2021
Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System
Igal Kushnir, Naveen S Basappa, Sunita Ghosh, et al.
European Urology
|
April 6, 2024
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study
Robert J Motzer, Toni K Choueiri, Thomas Hutson, et al.
Cancers
|
July 2, 2021
Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada
Christopher J D Wallis, Bobby Shayegan, Scott C Morgan, et al.
Journal of Geriatric Oncology
|
February 15, 2026
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada
Lauren Curry, Sunita Ghosh, Erica Arenovich, et al.
Prostate Cancer and Prostatic Diseases
|
February 24, 2022
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada
Bobby Shayegan, Christopher J D Wallis, Robert J Hamilton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 30, 2023
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial
James Chih-Hsin Yang, Baohui Han, Emmanuel De La Mora Jiménez, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 29, 2024
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer
Geoffrey T Gotto, Steven M Yip, Bobby Shayegan, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Urologic Oncology
|
May 18, 2023
Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population
Braden Millan, Rodney H Breau, Ranjeeta Mallick, et al.
Advances in Radiation Oncology
|
July 11, 2022
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System
Eric K Nguyen, Aly Khan A Lalani, Sunita Ghosh, et al.
JNCI Cancer Spectrum
|
December 20, 2021
Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate Cancer
Christopher J D Wallis, Shawn Malone, Ilias Cagiannos, et al.
Clinical Genitourinary Cancer
|
June 23, 2021
Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System
Igal Kushnir, Naveen S Basappa, Sunita Ghosh, et al.
European Urology
|
April 6, 2024
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study
Robert J Motzer, Toni K Choueiri, Thomas Hutson, et al.
Cancers
|
July 2, 2021
Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada
Christopher J D Wallis, Bobby Shayegan, Scott C Morgan, et al.
Journal of Geriatric Oncology
|
February 15, 2026
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada
Lauren Curry, Sunita Ghosh, Erica Arenovich, et al.
Prostate Cancer and Prostatic Diseases
|
February 24, 2022
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada
Bobby Shayegan, Christopher J D Wallis, Robert J Hamilton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 30, 2023
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial
James Chih-Hsin Yang, Baohui Han, Emmanuel De La Mora Jiménez, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 29, 2024
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer
Geoffrey T Gotto, Steven M Yip, Bobby Shayegan, et al.
Page
of 6